{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:19:11Z","timestamp":1785439151192,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.amjms.2022.12.010","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T01:54:13Z","timestamp":1671242053000},"page":"375-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["MicroRNA-19 upregulation attenuates cardiac fibrosis via targeting connective tissue growth factor"],"prefix":"10.1016","volume":"365","author":[{"given":"Xiaozheng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amjms.2022.12.010_bib0001","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.amjms.2022.12.010_bib0002","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"issue":"20","key":"10.1016\/j.amjms.2022.12.010_bib0003","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMra021498","article-title":"Heart failure","volume":"348","author":"Jessup","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0004","first-page":"59","article-title":"MicroRNAs in the development of left ventricular remodeling and postmyocardial infarction heart failure","volume":"130","author":"Sygitowicz","year":"2020","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0005","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1038\/s41467-020-18165-6","article-title":"Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy","volume":"11","author":"Luczak","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.010_bib0006","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ejhf.62","article-title":"Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology","volume":"16","author":"Tarone","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjms.2022.12.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103370","article-title":"TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-beta\/Smads and ERK1\/2 signaling pathways","volume":"67","author":"Cheng","year":"2021","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.amjms.2022.12.010_bib0008","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.amjms.2022.12.010_bib0009","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.amjms.2022.12.010_bib0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.amjms.2022.12.010_bib0011","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.amjms.2022.12.010_bib0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.010_bib0013","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1002\/jcp.27445","article-title":"The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis","volume":"234","author":"Javadian","year":"2018","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.amjms.2022.12.010_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.110.227496","article-title":"The art of microRNA research","volume":"108","author":"van Rooij","year":"2011","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1397344","article-title":"Overview of microRNA biology","volume":"35","author":"Mohr","year":"2015","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCHEARTFAILURE.113.000266","article-title":"MicroRNAs in heart failure: is the picture becoming less miRky?","volume":"7","author":"Melman","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.amjms.2022.12.010_bib0017","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/cvr\/cvr344","article-title":"Non-cardiomyocyte microRNAs in heart failure","volume":"93","author":"Tijsen","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.010_bib0018","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1474-9726.2011.00714.x","article-title":"MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure","volume":"10","author":"van Almen","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.amjms.2022.12.010_bib0019","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","article-title":"Connective tissue growth factor (CTGF) from basics to clinics","volume":"68-69","author":"Ramazani","year":"2018","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacbts.2018.10.007","article-title":"Connective tissue growth factor inhibition enhances cardiac repair and limits fibrosis after myocardial infarction","volume":"4","author":"Vainio","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"10","key":"10.1016\/j.amjms.2022.12.010_bib0021","doi-asserted-by":"crossref","first-page":"e25784","DOI":"10.1371\/journal.pone.0025784","article-title":"Inhibition of cardiac sympathetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure","volume":"6","author":"Gan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.amjms.2022.12.010_bib0022","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.12659\/MSM.898454","article-title":"Substance P inhibits the collagen synthesis of rat myocardial fibroblasts induced by Ang II","volume":"22","author":"Yang","year":"2016","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/21655979.2016.1227141","article-title":"Effect of testosterone on the proliferation and collagen synthesis of cardiac fibroblasts induced by angiotensin II in neonatal rat","volume":"8","author":"Yang","year":"2017","journal-title":"Bioengineered"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.010_bib0024","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1160\/th14-03-0243","article-title":"Tissue factor, protease activated receptors and pathologic heart remodelling","volume":"112","author":"Antoniak","year":"2014","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.amjms.2022.12.010_bib0025","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1097\/MIB.0000000000000443","article-title":"Low serum levels of MicroRNA-19 are associated with a stricturing crohn's disease phenotype","volume":"21","author":"Lewis","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0026","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/FJC.0000000000000752","article-title":"Ginsenoside Re preserves cardiac function and ameliorates left ventricular remodeling in a rat model of myocardial infarction","volume":"75","author":"Yu","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.amjms.2022.12.010_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172836","article-title":"Resiniferatoxin reduces ventricular arrhythmias in heart failure via selectively blunting cardiac sympathetic afferent projection into spinal cord in rats","volume":"867","author":"Wu","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.amjms.2022.12.010_bib0028","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.12659\/MSM.896983","article-title":"Effects of rosuvastatin and MiR-126 on myocardial injury induced by acute myocardial infarction in rats: role of vascular endothelial growth factor a (VEGF-A)","volume":"22","author":"Fei","year":"2016","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12867-019-0136-9","article-title":"Correction to: MicroRNA-325-3p protects the heart after myocardial infarction by inhibiting RIPK3 and programmed necrosis in mice","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Mol Biol"},{"issue":"7","key":"10.1016\/j.amjms.2022.12.010_bib0030","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.amjms.2022.12.010_bib0031","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00109-019-01833-6","article-title":"Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis","volume":"97","author":"Medzikovic","year":"2019","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.010_bib0032","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/ijms21010358","article-title":"Oxidative stress-responsive MicroRNAs in heart injury","volume":"21","author":"Kura","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjms.2022.12.010_bib0033","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2018.07.130","article-title":"CTGF\/CCN2 is an autocrine regulator of cardiac fibrosis","volume":"121","author":"Dorn","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.amjms.2022.12.010_bib0034","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.matbio.2020.04.002","article-title":"Regulators of cardiac fibroblast cell state","volume":"91-92","author":"Bretherton","year":"2020","journal-title":"Matrix Biol"},{"key":"10.1016\/j.amjms.2022.12.010_bib0035","article-title":"Selective HDAC8 inhibition attenuates isoproterenol-induced cardiac hypertrophy and fibrosis via p38 MAPK pathway","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.amjms.2022.12.010_bib0036","doi-asserted-by":"crossref","first-page":"e00728","DOI":"10.1002\/prp2.728","article-title":"Nobiletin ameliorates cardiac impairment and alleviates cardiac remodeling after acute myocardial infarction in rats via JNK regulation","volume":"9","author":"Liu","year":"2021","journal-title":"Pharmacol Res Perspect"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922004943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922004943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:16:10Z","timestamp":1762082170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922004943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0002962922004943"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.12.010","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-19 upregulation attenuates cardiac fibrosis via targeting connective tissue growth factor","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}